ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.

Richard D Baird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.